1. Home
  2. AVDL vs OMI Comparison

AVDL vs OMI Comparison

Compare AVDL & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • OMI
  • Stock Information
  • Founded
  • AVDL 2015
  • OMI 1882
  • Country
  • AVDL Ireland
  • OMI United States
  • Employees
  • AVDL N/A
  • OMI N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • OMI Medical Specialities
  • Sector
  • AVDL Health Care
  • OMI Health Care
  • Exchange
  • AVDL Nasdaq
  • OMI Nasdaq
  • Market Cap
  • AVDL 784.6M
  • OMI 545.4M
  • IPO Year
  • AVDL 1996
  • OMI N/A
  • Fundamental
  • Price
  • AVDL $9.46
  • OMI $7.09
  • Analyst Decision
  • AVDL Strong Buy
  • OMI Hold
  • Analyst Count
  • AVDL 7
  • OMI 6
  • Target Price
  • AVDL $18.86
  • OMI $12.83
  • AVG Volume (30 Days)
  • AVDL 1.2M
  • OMI 1.3M
  • Earning Date
  • AVDL 05-07-2025
  • OMI 05-08-2025
  • Dividend Yield
  • AVDL N/A
  • OMI N/A
  • EPS Growth
  • AVDL N/A
  • OMI N/A
  • EPS
  • AVDL N/A
  • OMI N/A
  • Revenue
  • AVDL $194,450,000.00
  • OMI $10,720,251,000.00
  • Revenue This Year
  • AVDL $50.53
  • OMI $4.28
  • Revenue Next Year
  • AVDL $32.33
  • OMI $2.92
  • P/E Ratio
  • AVDL N/A
  • OMI N/A
  • Revenue Growth
  • AVDL 252.64
  • OMI 2.84
  • 52 Week Low
  • AVDL $6.38
  • OMI $6.07
  • 52 Week High
  • AVDL $17.85
  • OMI $21.02
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 65.93
  • OMI 42.21
  • Support Level
  • AVDL $8.55
  • OMI $6.83
  • Resistance Level
  • AVDL $9.98
  • OMI $8.60
  • Average True Range (ATR)
  • AVDL 0.50
  • OMI 0.51
  • MACD
  • AVDL 0.11
  • OMI 0.10
  • Stochastic Oscillator
  • AVDL 77.73
  • OMI 28.14

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About OMI Owens & Minor Inc.

Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.

Share on Social Networks: